Paivi Pietila-Effati
Overview
Explore the profile of Paivi Pietila-Effati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poyhonen P, Lehtonen J, Syvaranta S, Velikanova D, Malkonen H, Simonen P, et al.
Circ Arrhythm Electrophysiol
. 2024 Dec;
18(1):e013239.
PMID: 39704049
Background: Cardiac sarcoidosis involves a significant but difficult-to-define risk of sudden cardiac death (SCD). Current guidelines recommend consideration of an implantable cardioverter defibrillator for patients with extensive or significant myocardial...
2.
Poyhonen P, Lehtonen J, Velikanova D, Simonen P, Uusitalo V, Malkonen H, et al.
JACC Adv
. 2024 Aug;
3(8):101102.
PMID: 39105120
Background: Cardiac sarcoidosis (CS) is a rare but potentially fatal inflammatory cardiomyopathy. Objectives: The authors studied temporal changes in the incidence, characteristics, and outcome of CS. Methods: A retrospective analysis...
3.
Velikanova D, Poyhonen P, Lehtonen J, Simonen P, Uusitalo V, Vihinen T, et al.
Circulation
. 2024 Mar;
149(11):885-887.
PMID: 38466785
No abstract available.
4.
Pietila-Effati P, Saarinen J, Loyttyniemi E, Saarenhovi M, Autio R, Kantola I
Am J Med Genet A
. 2023 Apr;
191(7):1858-1869.
PMID: 37078610
Fabry disease (FD) is an X chromosome-linked, life-threatening lysosomal disease caused by one of more than 1000 currently known variants in the α-galactosidase A (GLA) gene. The follow-up part of...
5.
Nordenswan H, Poyhonen P, Lehtonen J, Ekstrom K, Uusitalo V, Niemela M, et al.
Circulation
. 2022 Aug;
146(13):964-975.
PMID: 36000392
Background: Cardiac sarcoidosis (CS) predisposes to sudden cardiac death (SCD). Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the Heart Rhythm Society in 2014 and the...
6.
Pietila-Effati P, Hoglund M, Karajamaki A, Hoglund F, Nabb A, Matila E, et al.
Scand Cardiovasc J
. 2022 May;
56(1):103-106.
PMID: 35587165
Cardiac resynchronization therapy (CRT) reduces the morbidity and mortality in advanced heart failure (HF) in about two-thirds of the patients. Approximately one-third of the patients do not respond to CRT....
7.
Pietila-Effati P, Soderstrom J, Saarinen J, Loyttyniemi E, Kantola I
Mol Genet Genomic Med
. 2022 Mar;
10(5):e1915.
PMID: 35246967
Background: Fabry disease (FD) is caused by a defect in α-galactosidase A gene (GLA) which leads to a progressive accumulation of neutral shingolipids, mainly globotriaosylceramide and its metabolites in several...
8.
Nordenswan H, Lehtonen J, Ekstrom K, Raisanen-Sokolowski A, Mayranpaa M, Vihinen T, et al.
J Am Heart Assoc
. 2021 Mar;
10(6):e019415.
PMID: 33660520
Background Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) share many histopathologic and clinical features. Whether they are parts of a one-disease continuum has been discussed. Methods and Results We...
9.
Pieroni M, Moon J, Arbustini E, Barriales-Villa R, Camporeale A, Cokan Vujkovac A, et al.
J Am Coll Cardiol
. 2021 Feb;
77(7):922-936.
PMID: 33602475
Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide (Gb3) in affected tissues, including the...
10.
Pietila-Effati P, Saarinen J, Loyttyniemi E, Autio R, Saarenhovi M, Haanpaa M, et al.
Mol Genet Genomic Med
. 2019 Aug;
7(10):e00930.
PMID: 31411008
Background: Fabry disease is caused by a deficient or an absent alfa-galactosidase A activity and is an X-linked disorder that results in organ damage and a shortened life span, especially...